A citation-based method for searching scientific literature

Jack J H Bleesing. Curr Pharm Des 2003
Times Cited: 22







List of co-cited articles
83 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome.
G H Fisher, F J Rosenberg, S E Straus, J K Dale, L A Middleton, A Y Lin, W Strober, M J Lenardo, J M Puck. Cell 1995
27

A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease.
M C Sneller, S E Straus, E S Jaffe, J S Jaffe, T A Fleisher, M Stetler-Stevenson, W Strober. J Clin Invest 1992
232
27

Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis.
M C Sneller, J Wang, J K Dale, W Strober, L A Middelton, Y Choi, T A Fleisher, M S Lim, E S Jaffe, J M Puck,[...]. Blood 1997
269
27

The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis.
S E Straus, E S Jaffe, J M Puck, J K Dale, K B Elkon, A Rösen-Wolff, A M Peters, M C Sneller, C W Hallahan, J Wang,[...]. Blood 2001
307
27

Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance.
C E Jackson, R E Fischer, A P Hsu, S M Anderson, Y Choi, J Wang, J K Dale, T A Fleisher, L A Middelton, M C Sneller,[...]. Am J Hum Genet 1999
162
22

Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity.
F Rieux-Laucat, F Le Deist, C Hivroz, I A Roberts, K M Debatin, A Fischer, J P de Villartay. Science 1995
22

Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome.
J J Bleesing, M R Brown, S E Straus, J K Dale, R M Siegel, M Johnson, M J Lenardo, J M Puck, T A Fleisher. Blood 2001
93
22


Autoimmune lymphoproliferative syndrome.
Michael C Sneller, Janet K Dale, Stephen E Straus. Curr Opin Rheumatol 2003
63
18

An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome.
S E Straus, M Sneller, M J Lenardo, J M Puck, W Strober. Ann Intern Med 1999
230
18

Autoimmune lymphoproliferative syndromes: genetic defects of apoptosis pathways.
F Rieux-Laucat, F Le Deist, A Fischer. Cell Death Differ 2003
149
18


Increases in circulating and lymphoid tissue interleukin-10 in autoimmune lymphoproliferative syndrome are associated with disease expression.
U Lopatin, X Yao, R K Williams, J J Bleesing, J K Dale, D Wong, J Teruya-Feldstein, S Fritz, M R Morrow, I Fuss,[...]. Blood 2001
74
13

Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency.
Hyung J Chun, Lixin Zheng, Manzoor Ahmad, Jin Wang, Christina K Speirs, Richard M Siegel, Janet K Dale, Jennifer Puck, Joie Davis, Craig G Hall,[...]. Nature 2002
501
13

Lymphoproliferative syndrome with autoimmunity: A possible genetic basis for dominant expression of the clinical manifestations.
F Rieux-Laucat, S Blachère, S Danielan, J P De Villartay, M Oleastro, E Solary, B Bader-Meunier, P Arkwright, C Pondaré, F Bernaudin,[...]. Blood 1999
117
13

Pathological findings in human autoimmune lymphoproliferative syndrome.
M S Lim, S E Straus, J K Dale, T A Fleisher, M Stetler-Stevenson, W Strober, M C Sneller, J M Puck, M J Lenardo, K S Elenitoba-Johnson,[...]. Am J Pathol 1998
146
13

Autoimmune lymphoproliferative syndrome with somatic Fas mutations.
Eliska Holzelova, Cédric Vonarbourg, Marie-Claude Stolzenberg, Peter D Arkwright, Françoise Selz, Anne-Marie Prieur, Stéphane Blanche, Jirina Bartunkova, Etienne Vilmer, Alain Fischer,[...]. N Engl J Med 2004
195
13

Cell-death signaling and human disease.
Frédéric Rieux-Laucat, Alain Fischer, Françoise Le Deist. Curr Opin Immunol 2003
90
13

Rapamycin improves lymphoproliferative disease in murine autoimmune lymphoproliferative syndrome (ALPS).
David T Teachey, Dana A Obzut, Kelly Axsom, John K Choi, Kelly C Goldsmith, Junior Hall, Jessica Hulitt, Catherine S Manno, John M Maris, Nicholas Rhodin,[...]. Blood 2006
62
13

Use of rituximab for refractory cytopenias associated with autoimmune lymphoproliferative syndrome (ALPS).
V Koneti Rao, Susan Price, Katie Perkins, Patricia Aldridge, Jean Tretler, Joie Davis, Janet K Dale, Fred Gill, Kip R Hartman, Linda C Stork,[...]. Pediatr Blood Cancer 2009
57
13

Treatment with sirolimus results in complete responses in patients with autoimmune lymphoproliferative syndrome.
David T Teachey, Robert Greiner, Alix Seif, Edward Attiyeh, Jack Bleesing, John Choi, Catherine Manno, Eric Rappaport, Dirk Schwabe, Cecilia Sheen,[...]. Br J Haematol 2009
108
13

Mycophenolate mofetil as an alternate immunosuppressor for autoimmune lymphoproliferative syndrome.
Lydia Kossiva, Maria Theodoridou, Glykeria Mostrou, Effie Vrachnou, Francoise Le Deist, Frederick Rieux-Laucat, Maria G Kanariou. J Pediatr Hematol Oncol 2006
13
23

NRAS mutation causes a human autoimmune lymphoproliferative syndrome.
João B Oliveira, Nicolas Bidère, Julie E Niemela, Lixin Zheng, Keiko Sakai, Cynthia P Nix, Robert L Danner, Jennifer Barb, Peter J Munson, Jennifer M Puck,[...]. Proc Natl Acad Sci U S A 2007
149
13

The Fas death factor.
S Nagata, P Golstein. Science 1995
13

Autoimmune lymphoproliferative syndrome. A human disorder of abnormal lymphocyte survival.
J J Bleesing, S E Straus, T A Fleisher. Pediatr Clin North Am 2000
61
13

FAS-L, IL-10, and double-negative CD4- CD8- TCR alpha/beta+ T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of function.
Aude Magerus-Chatinet, Marie-Claude Stolzenberg, Maria S Loffredo, Bénédicte Neven, Catherine Schaffner, Nicolas Ducrot, Peter D Arkwright, Brigitte Bader-Meunier, José Barbot, Stéphane Blanche,[...]. Blood 2009
96
13

Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency.
Waleed Al-Herz, Aziz Bousfiha, Jean-Laurent Casanova, Talal Chatila, Mary Ellen Conley, Charlotte Cunningham-Rundles, Amos Etzioni, Jose Luis Franco, H Bobby Gaspar, Steven M Holland,[...]. Front Immunol 2014
298
13

Practice parameter for the diagnosis and management of primary immunodeficiency.
Francisco A Bonilla, David A Khan, Zuhair K Ballas, Javier Chinen, Michael M Frank, Joyce T Hsu, Michael Keller, Lisa J Kobrynski, Hirsh D Komarow, Bruce Mazer,[...]. J Allergy Clin Immunol 2015
308
13


Missense mutations in the Fas gene resulting in autoimmune lymphoproliferative syndrome: a molecular and immunological analysis.
A Bettinardi, D Brugnoni, E Quiròs-Roldan, A Malagoli, S La Grutta, A Correra, L D Notarangelo. Blood 1997
157
9

The clinical spectrum in a large kindred with autoimmune lymphoproliferative syndrome caused by a Fas mutation that impairs lymphocyte apoptosis.
A J Infante, H A Britton, T DeNapoli, L A Middelton, M J Lenardo, C E Jackson, J Wang, T Fleisher, S E Straus, J M Puck. J Pediatr 1998
88
9

Clinical, immunological, and pathological consequences of Fas-deficient conditions.
F Le Deist, J F Emile, F Rieux-Laucat, M Benkerrou, I Roberts, N Brousse, A Fischer. Lancet 1996
152
9

Aire deficient mice develop multiple features of APECED phenotype and show altered immune response.
Chris Ramsey, Ola Winqvist, Lea Puhakka, Maria Halonen, Aune Moro, Olle Kämpe, Petra Eskelin, Markku Pelto-Huikko, Leena Peltonen. Hum Mol Genet 2002
348
9

Novel Fas (CD95/APO-1) mutations in infants with a lymphoproliferative disorder.
Y Kasahara, T Wada, Y Niida, A Yachie, H Seki, Y Ishida, T Sakai, F Koizumi, S Koizumi, T Miyawaki,[...]. Int Immunol 1998
72
9


Mature T lymphocyte apoptosis--immune regulation in a dynamic and unpredictable antigenic environment.
M Lenardo, K M Chan, F Hornung, H McFarland, R Siegel, J Wang, L Zheng. Annu Rev Immunol 1999
783
9


Positive and negative selection of T cells.
Timothy K Starr, Stephen C Jameson, Kristin A Hogquist. Annu Rev Immunol 2003
9



Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis.
R Watanabe-Fukunaga, C I Brannan, N G Copeland, N A Jenkins, S Nagata. Nature 1992
9

Pyrimethamine treatment does not ameliorate lymphoproliferation or autoimmune disease in MRL/lpr-/- mice or in patients with autoimmune lymphoproliferative syndrome.
V Koneti Rao, Kennichi C Dowdell, Janet K Dale, Faith Dugan, Lesley Pesnicak, Lilia L Bi, Victoria Hoffmann, Scott Penzak, Nilo A Avila, Thomas A Fleisher,[...]. Am J Hematol 2007
12
16

Effect of anti-CD20 (rituximab) on resistant thrombocytopenia in autoimmune lymphoproliferative syndrome.
Bridget T Heelan, Vincent Tormey, Peter Amlot, Elspeth Payne, Atul Mehta, A David B Webster. Br J Haematol 2002
24
9

Reversion of autoimmune lymphoproliferative syndrome with an antimalarial drug: preliminary results of a clinical cohort study and molecular observations.
Jutte van der Werff Ten Bosch, Peter Schotte, Alice Ferster, Nadira Azzi, Thomas Boehler, Geneviève Laurey, Mikko Arola, Christian Demanet, Rudi Beyaert, Kris Thielemans,[...]. Br J Haematol 2002
31
9

Rapamycin is active against B-precursor leukemia in vitro and in vivo, an effect that is modulated by IL-7-mediated signaling.
Valerie I Brown, Junjie Fang, Keith Alcorn, Rosalind Barr, Jenny M Kim, Robert Wasserman, Stephan A Grupp. Proc Natl Acad Sci U S A 2003
134
9

Correction of autoimmune lymphoproliferative syndrome by bone marrow transplantation.
B J Sleight, V S Prasad, C DeLaat, P Steele, E Ballard, R J Arceci, C L Sidman. Bone Marrow Transplant 1998
38
9

A composite picture of TcR alpha/beta(+) CD4(-)CD8(-) T Cells (alpha/beta-DNTCs) in humans with autoimmune lymphoproliferative syndrome.
Jack J H Bleesing, Margaret R Brown, Cynthia Novicio, David Guarraia, Janet K Dale, Stephen E Straus, Thomas A Fleisher. Clin Immunol 2002
57
9

Autoimmune lymphoproliferative syndrome, a disorder of apoptosis.
C E Jackson, J M Puck. Curr Opin Pediatr 1999
59
9

Mycophenolate mofetil interferes with interferon gamma production in T-cell activation models.
K Izeradjene, L Quemeneur, M C Michallet, N Bonnefoy-Berard, J P Revillard. Transplant Proc 2001
11
18



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.